SCHEMBL2474256

SCHEMBL2474256

NC(=O)c1c(O)cc(O)cc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.56
MEN1 O00255 5/20 0.56
KMT2A Q03164 5/20 0.56
HPGD P15428 2/20 0.56
FASN P49327 1/20 0.54
PTGS1 P23219 1/20 0.50
DRD3 P35462 1/20 0.50
ACHE P22303 2/20 0.48
NR1H2 P55055 1/20 0.45
NR1H3 Q13133 1/20 0.45
POLB P06746 2/20 0.41
MAPT P10636 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
SLC5A1 P13866 2/20 0.41
SLC5A2 P31639 2/20 0.41
KDM4E B2RXH2 1/20 0.41
SLC16A3 O15427 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
TTR P02766 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31738485 0.84 CYP3A4 (0.67) CYP3A4MEN1KMT2AHPGDFASN
SCHEMBL6272879 0.77 FASN (0.75) CYP3A4MEN1KMT2AHPGDFASN
SCHEMBL6858883 0.74 CYP3A4 (0.59) CYP3A4MEN1KMT2AHPGDFASN
SCHEMBL5603948 0.74 CYP3A4 (0.70) CYP3A4MEN1KMT2AHPGDFASN
SCHEMBL180437 0.74 CYP3A4 (0.70) CYP3A4MEN1KMT2AHPGDFASN
SCHEMBL7530230 0.74 CYP3A4 (0.56) CYP3A4MEN1KMT2AHPGDACHE
SCHEMBL5173533 0.74 CYP3A4 (0.48) CYP3A4MEN1KMT2AHPGDFASN
SCHEMBL7983328 0.73 NQO1 (0.48) CYP3A4MEN1KMT2AHPGDFASN
SCHEMBL8215504 0.72 CYP3A4 (0.67) CYP3A4MEN1KMT2AHPGDFASN
2,4,6-Trihydroxyacetophenone SCHEMBL105416 0.72 CYP3A4 (1.00) CYP3A4MEN1KMT2AHPGDFASN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210171883-A1 ANTIVIRAL WIPER FUJIFILM CORPORATION (JP) 2021-06-10 US disclosed
EP-2527451-A1 Screening method for identifying genes involved in plant cell cycle VIB VZM (BE) 2012-11-28 EP disclosed
EP-2373797-A1 SCREENING METHOD FOR IDENTIFYING GENES INVOLVED IN PLANT CELL CYCLE VIB VZW (BE) 2011-10-12 EP disclosed
WO-2010066849-A1 SCREENING METHOD FOR IDENTIFYING GENES INVOLVED IN PLANT CELL CYCLE VIB VZW (BE) 2010-06-17 WO disclosed
US-4448730-A ANTITUMOR AGENTS RIET BARTHOLOMEUS VAN T 1984-05-15 US disclosed
US-4394389-A ANTITUMOR AGENTS RIET BARTHOLOMEUS VAN T 1983-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210171883-A1 ANTIVIRAL WIPER CGAS, PRKX, PDE4C CYP3A4 4047/4885MEN1 3305/4885KMT2A 1885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.